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Transiliac Bone Biopsy 
Complications and diagnostic value 
Sudhaker D. Rao, MB, BS,* Velimir Matkovic, MD, PhD,** and Howard Duncan, MB, BS' 
This article reviews the experience of 101 transiliac bone 
biopsies performed in one year at Henry Ford Hospital and 
discusses the possible diagnostic value ofthe procedure in 
evaluating generalized metabolic bone disease. In 50 ofthe 
101 cases, we used a pain scoring method to evaluate the 
acceptability of the procedure to patients. Data from our 
study and 18 other clinical centers were then analyzed for: 
I) demographic distribution of patients who had a bone 
biopsy; 2) its acceptability to patients; 3) quality of the 
specimen and its relationship to the physician performing 
the procedure; 4) diagnostic yield of bone biopsy; and 5) 
complications of the procedure. Transiliac bone biopsy is 
reasonably acceptable to patients and does not sacrifice the 
quality of bone needed for diagnostic purposes. With im-
proved instrumentation, it can be performed on outpatients 
and does not require elaborate physical facilities. We con-
clude that transiliac bone biopsy should be performed on 
all patients with metabolic bone disease unless the diag-
nosis is obvious. 
Histo logic examination of tissue biopsy specimens has 
become an integral part of medicine. With improved in-
strumentation many procedures can now be performed in 
outpatients and do not require elaborate physical facilities. 
Transiliac bone biopsy is no exception (1,2). It provides an 
adequate sample both for diagnosis and for micromor-
phometric and histodynamic study of bone in various 
metabolic bone diseases. While bone biopsy has been a 
routine procedure to identify local lesions for some dec-
ades, its use in evaluating generalized metabolic bone 
disease has received little attention. Although transiliac 
bone biopsy is considered a research tool by many physi-
cians, this article describes its use as a diagnostic aid in the 
field of bone and mineral metabolism. The detailed tech-
nique of performing a bone biopsy is discussed elsewhere 
(3). Essentially it consists of removing a small core of 
cortical and trabecular bone from the ilium approximately 
* Bone and Mineral Research Laboratory Department of Internal Medi-
cine, Henry Ford Hospital 
** Formerly, Bone and Mineral Research Laboratory, Henry Ford Hospi-
tal; presently. Institute for Medical Research and Occupational Health, 
Zagreb, Yugoslavia 
' * * Division of Rheumatology, Department of Internal Medicine, Henry 
Ford Hospital 
Address reprint requests to Dr. Rao, Department of Internal Medicine, 
Henry Ford Hospital, 2799 W Grand Blvd, Detroit, Ml 48202 
3 cms posterior and 3 cms inferior to anterior superior iliac 
spine, through a small skin and muscle incision (3). 
Materials and Methods 
Between January and December 1979, 101 transiliac bone 
biopsies were performed by three physicians (A, B, and C) 
at Henry Ford Hospital. Physician A learned the procedure 
from physician C and taught it to physician B. In vivo, 
double tetracycline labeling was used for all patients prior 
to bone biopsy, so that measurements of histodynamic data 
on the specimen could be made (4,5). 
As a part of the study, data from 18 clinical centers where 
bone biopsies are performed were pooled for analysis of 
complications (6). Data were analyzed for: 1) demographic 
distribution of patients who had a bone biopsy; 2) its 
acceptability to patients (see pain score below); 3) quality 
o f the specimen and its relationship to the physician per-
forming the procedure; 4) diagnostic yield of bone biopsy; 
and 5) complications of the procedure. 
To determine a pain score, we assessed patient discomfort 
on a scale of 0 to 4: 0, no discomfort; 1, mild; 2, moderate; 
3, severe; 4, excruciating or unbearable. Pain scoring was 
done only for patients of physician A and was initiated 
during the latter part ofthe study so that a total of only 50 
consecutive patients were available for analysis. Scoring 
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was done once at the end ofthe procedure and again when 
sutures were removed seven days later. Ancillary personnel 
and the patient's own physicians helped in overall assess-
ment of pain score. 
Results 
There were 85 women and 16 men (Table I). As a group, 
men were five years younger than women, but the mean 
value was not significantly different. Black men were the 
youngest of the group (<50 years of age), but in each 
patient a secondary cause for accelerated bone loss was 
present: two had renal osteodystrophy, one had total gas-
trectomy for Zollinger-Ellison syndrome, and one had in-
sul in-dependent diabetes mel l i tus. The pattern of 
distribution by age, sex, and race is similar to that for 
osteoporotic patients in general. 
Fifty patients were evaluated for pain by the pain scoring 
method. A further analysis related the pain score to the 
number of bone biopsies each patient received (Table 11). 
Thirty-eight patients (76%) considered the discomfort as '0' 
or ' 1 ' . Twenty-seven had the procedure for the first time and 
10 for the second time, eight of whom scored their discom-
fort as ' 1 ' . We could not assess the previous experience of 
these eight patients, since the biopsy had been performed 
by a different physician and the pain score had not been 
determined. However, they admitted that the second pro-
TABLEI 
Characteristics of Population Studied 
Age (Years) 
Score 
TABLE II 
Pain Score (Physician A Only) 
No. of No. of patients 
patients in each encounter 
Race and Sex Number (Mean ± SD) 
White Women 74 60.0 ±11.9 
White Men 12 55.7 ±11.0 
Black Women 11 62.2 ± 8.7 
Black Men 4 48.7 ± 2.0 
Total 
Women 85 60.3 ±11.6 
Men 16 54.3 ± 10.3 
cedure was less painful than the previous one. Patients' 
knowledge of the procedure or the physician's technical 
expertise or both could have contributed to their assess-
ment of less discomfort. This assumption is supported by 
the fact that one patient scored '0' even at the fourth 
encounter. Eleven patients (22%) scored '2 ' (nine were first 
encounters and two were third encounters). In the latter 
two patients, biopsies were performed by the same physi-
cian (physician A) on each of the three encounters. They 
accepted the procedure because of its value in their man-
agement, despite considerable discomfort experienced. 
One patient (2%) scored '3', and none scored '4' . 
1st 2nd Srd 4th 
0 12 9 2 — 1 
1 26 18 8 — — 
2 11 9 — 2 — 
3 1 1 — — — 
4 0 
— — — — 
Quality ofthe bone specimen was satisfactory in 88 (88%) 
cases (Table III). Physician B obtained the highest number 
of unsatisfactory specimens, and physician A the least. 
Both physician A and C had previously performed more 
than 150 transiliac bone biopsies, whereas physician B had 
no previous experience. Thus, the quality of specimen 
relates to the experience ofthe physician who performs the 
procedure. Twelve specimens (12%) were unsatisfactory 
(fragmented, one cortex missing, crushed trabeculae, etc), 
but were sufficient for diagnostic purposes. The mean 
volume of bone specimen was 0.2723 cm^* (0.1130-
0.5770 cm^). Geometric shape, technical artifacts and, 
presumably, underlying metabolic process all might have 
contr ibuted to the wide var iat ion in bone specimen 
volume. 
Histologic diagnoses of bone biopsy showed osteoporosis 
in 83 patients, osteomalacia in 11, and renal osteodystro-
phy in 7. Among 83 patients with osteoporosis, 9 (11 %) had 
a skeletal imbalance consisting of a dichotomy between 
cortical and trabecular histodynamics, 15(18%) had a high 
turnover of bone (i.e., increased cellular activity of both 
osteoblasts and osteoclasts), and 59 (80%) had a low 
turnover of bone (i.e., decreased cellular activity of both 
osteoblasts and osteoclasts). Clinical, biochemical, and 
radiologic features ofthe last two groups with osteoporosis 
were indistinguishable. In four of 11 patients with histologic 
osteomalacia, laboratory data were inconclusive so that the 
diagnosis was established exclusively by bone biopsy. Two 
patients with renal osteodystrophy had features of predomi-
nant osteomalacia, four showed features of excess para-
thyroid hormone effect, and one showed improvement of 
osteomalacia as a therapeutic response. One patient in the 
entire group showed osteomalacia that was totally unex-
pected and is still under investigation for proper diagnosis. 
Table IV illustrates the complications from the bone biopsy. 
One patient with renal osteodystrophy developed local 
hematoma as a result ofthe procedure, probably related to 
' V=Lx3.14x(D/2)^ where L is the length ofthe specimen, which in turn 
reflects the thickness of the ilium; D is the diameter of the specimen 
which cannot exceed 0.7 cm. 
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heparin use during subsequent hemodialysis, and it re-
solved spontaneously. Bone specimens were lost internally 
(between the iliacus muscle and inner aspect ofthe ilium) 
or externally (external to the bone in subcutaneous tissue 
under the fascia lata). Eight specimens lost externally were 
retrieved easily by digital exploration without additional 
discomfort to the patient. Two specimens lost internally 
(one each by physicians A and C) were left in vivo; both 
patients were informed but neither developed any long-
term complications as a result. In both cases, a second 
biopsy was done adjacent to the previously attempted site. 
In another case, the cutting end of the trephine separated 
from the shaft after pentrating the outer cortex of the ilium 
but was removed with a pair of pliers. A successful second 
attempt was made without complications. Interestingly, this 
patient's pain score was ' 1 ' . None of our patients experi-
enced complications such as femoral nerve palsy (transient 
or permanent), skeletal fractures (local or distant), wound 
infections, or osteomyelitis. A few patients experienced 
local dysesthesia for up to four months, but it resolved 
completely with time. 
Discussion 
At present, several types of instruments and approaches for 
obtaining a bone biopsy are available (3). Transiliac bone 
biopsy is probably the method most often used since the 
TABLE III 
Quality of Specimen 
% 
Satis- Unsatis- Unsatis- Previous 
Physician Total Factory Factory Factory Experience 
TABLE V 
A 48 44 4 8°'o Yes 
B 42 35 7 17% No 
C 9 8 1 11% Yes 
TABLE IV 
Complications of Transiliac Bone Biopsy 
Complications No. of patients % 
Total Number 
of patients 101 100 
Hematoma 1 1 
Instrument problem 1 1 
Specimens lost* 2 2 
Femoral nerve palsy 
— — 
Wound infection — — 
Skeletal fracture — — 
Osteomyelitis — 
Total 4 4% 
Bone Biopsy Complications 
Transiliac Iliac 
Trephine Crest 
No. of Cases 9,030 5,780 
Hematoma 21 14 
Neuropathy 11 2 
Wound infection (Skin) 6 4 
Pain (7 days) 17 
— 
Fracture 2 
— 
Osteomyelitis 1 — 
Total No. of 58* 20* 
Complications (0.64%) (0.35%) 
* See text for explanation. 
* Not significantly different. 
ilium is an easily accessible site. A lateral approach (1) 
offers the best opportunity for obtaining a full thickness 
(with both inner and outer cortices of ilium) iliac bone 
specimen of good quality and of sufficient quantity. 
Complications are either transient or non-existent. Pain is 
the single most common complication, but it is reasonably 
well accepted, as described above. In a larger survey of 
9,030 transiliac bone biopsies compiled from 18 major 
centers, the incidence of complications was similar to those 
ofthis study (Table V). Furthermore, the incidence did not 
significantly differ between the superior (needle trephine) 
and lateral (transiliac trephine) approach nor between the 
instruments used. Patient acceptability is good, as shown 
by the data presented here and as has been reported in a 
similar study (7). If necessary precautions are taken (3), the 
procedure is no more complicated than any other form of 
biopsy. Contrary to the previous report (3), incision of 
subcutaneous tissue and fascia lata, rather than blunt dis-
section, greatly minimizes the discomfort of patients during 
or for several days after the procedure. The incised fascia 
lata must be sutured with interrupted, absorbable chromic 
material to avoid herniation of underlying muscle. 
Diagnostic usefulness of bone biopsy is evident when the 
spectrum of histologic findings within the same disease 
entity is considered. Although noninvasive techniques 
(clinical, biochemical, and radiologic) are often helpful, a 
small but significant number of patients wil l require bone 
biopsy either to confirm the diagnosis or guide therapeutic 
decision. This is particularly important in patients with 
osteoporosis and with renal osteodystrophy, where the 
nature of bone disease is not always obvious (8). In another 
group of patients with postgastrectomy osteopenia (9), 
25% had osteomalacia, despite normal dietary intake of 
calcium and calciferol. None of the laboratory data were 
helpful in predicting bone histology in this group (9). 
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In summary, transiliac bone biopsy can be performed in 
outpatients with minimal discomfort. It is reasonably ac-
ceptable to patients without sacrificing the quality of bone 
needed for diagnostic purposes. Because of its ease and 
high diagnostic yield, it should be performed in all patients 
w i th metabol ic bone disease unless the diagnosis is 
obvious. 
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